Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Glucose transporter 3 and 1 may facilitate high uptake of 18F-FDG in gastric schwannoma.

Shimada Y, Sawada S, Hojo S, Okumura T, Nagata T, Nomoto K, Tsukada K.

Clin Nucl Med. 2013 Nov;38(11):e417-20. doi: 10.1097/RLU.0b013e318279f0d9.

PMID:
24096997
4.

Gastric schwannomas show an obviously increased fluorodeoxyglucose uptake in positron emission tomography: report of two cases.

Ohno T, Ogata K, Kogure N, Ando H, Aihara R, Mochiki E, Zai H, Sano A, Kato T, Sakurai S, Oyama T, Asao T, Kuwano H.

Surg Today. 2011 Aug;41(8):1133-7. doi: 10.1007/s00595-010-4401-2. Epub 2011 Jul 20.

PMID:
21773906
5.

Variable 18F-fluorodeoxyglucose uptake in gastric cancer is associated with different levels of GLUT-1 expression.

Alakus H, Batur M, Schmidt M, Drebber U, Baldus SE, Vallböhmer D, Prenzel KL, Metzger R, Bollschweiler E, Hölscher AH, Mönig SP.

Nucl Med Commun. 2010 Jun;31(6):532-8. doi: 10.1097/MNM.0b013e32833823ac.

PMID:
20220543
6.

Biologic correlation between glucose transporters, hexokinase-II, Ki-67 and FDG uptake in malignant melanoma.

Park SG, Lee JH, Lee WA, Han KM.

Nucl Med Biol. 2012 Nov;39(8):1167-72. doi: 10.1016/j.nucmedbio.2012.07.003. Epub 2012 Aug 15.

PMID:
22901702
7.

18F-FDG-PET of musculoskeletal tumors: a correlation with the expression of glucose transporter 1 and hexokinase II.

Hamada K, Tomita Y, Qiu Y, Zhang B, Ueda T, Myoui A, Higuchi I, Yoshikawa H, Aozasa K, Hatazawa J.

Ann Nucl Med. 2008 Oct;22(8):699-705. doi: 10.1007/s12149-008-0173-9. Epub 2008 Nov 4.

PMID:
18982473
8.

FDG uptake and glucose transporter type 1 expression in lymph nodes of non-small cell lung cancer.

Chung JH, Lee WW, Park SY, Choe G, Sung SW, Chung JK, Lee MC, Kim SE.

Eur J Surg Oncol. 2006 Nov;32(9):989-95. Epub 2006 Jul 20.

PMID:
16859874
9.

Correlation of Glut-1 glucose transporter expression with.

Higashi K, Ueda Y, Sakurai A, Wang XM, Xu L, Murakami M, Seki H, Oguchi M, Taki S, Nambu Y, Tonami H, Katsuda S, Yamamoto I.

Eur J Nucl Med. 2000 Dec;27(12):1778-85.

PMID:
11189940
10.

FDG uptake, GLUT-1 glucose transporter and cellularity in human pancreatic tumors.

Higashi T, Tamaki N, Torizuka T, Nakamoto Y, Sakahara H, Kimura T, Honda T, Inokuma T, Katsushima S, Ohshio G, Imamura M, Konishi J.

J Nucl Med. 1998 Oct;39(10):1727-35.

11.

No relationship between 18F-fluorodeoxyglucose positron emission tomography and expression of Glut-1 and -3 and hexokinase I and II in high-grade glioma.

Charnley N, Airley R, Du Plessis D, West C, Brock C, Barnett C, Matthews J, Symonds K, Bottomly M, Swindell R, Price P.

Oncol Rep. 2008 Sep;20(3):537-42.

PMID:
18695903
12.

P-glycoprotein expression affects 18F-fluorodeoxyglucose accumulation in hepatocellular carcinoma in vivo and in vitro.

Seo S, Hatano E, Higashi T, Nakajima A, Nakamoto Y, Tada M, Tamaki N, Iwaisako K, Kitamura K, Ikai I, Uemoto S.

Int J Oncol. 2009 May;34(5):1303-12.

PMID:
19360342
13.

(18)F-FDG PET analysis of schwannoma: increase of SUVmax in the delayed scan is correlated with elevated VEGF/VPF expression in the tumors.

Hamada K, Tomita Y, Qiu Y, Tomoeda M, Ueda T, Tamai N, Hashimoto N, Yoshikawa H, Aozasa K, Hatazawa J.

Skeletal Radiol. 2009 Mar;38(3):261-6. doi: 10.1007/s00256-008-0612-7. Epub 2008 Dec 17.

PMID:
19089420
14.

Expression of GLUT-1 and GLUT-3 in xanthogranulomatous cholecystitis induced a positive result on ¹⁸F-FDG PET: report of a case.

Sawada S, Shimada Y, Sekine S, Shibuya K, Yoshioka I, Matsui K, Okumura T, Yoshida T, Nagata T, Uotani H, Tsukada K.

Int Surg. 2013 Oct-Dec;98(4):372-8. doi: 10.9738/INTSURG-D-13-00092.1.

15.

Gastric schwannoma exhibiting increased fluorodeoxyglucose uptake.

Komatsu D, Koide N, Hiraga R, Furuya N, Akamatsu T, Uehara T, Miyagawa S.

Gastric Cancer. 2009;12(4):225-8. doi: 10.1007/s10120-009-0526-7. Epub 2010 Jan 5.

PMID:
20047128
16.

Correlation of 18-F-fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma.

Kato H, Takita J, Miyazaki T, Nakajima M, Fukai Y, Masuda N, Fukuchi M, Manda R, Ojima H, Tsukada K, Kuwano H, Oriuchi N, Endo K.

Anticancer Res. 2003 Jul-Aug;23(4):3263-72.

PMID:
12926062
17.

Expression of Glut-1 and Glut-3 in untreated oral squamous cell carcinoma compared with FDG accumulation in a PET study.

Tian M, Zhang H, Nakasone Y, Mogi K, Endo K.

Eur J Nucl Med Mol Imaging. 2004 Jan;31(1):5-12. Epub 2003 Oct 10.

PMID:
14551748
18.

18F-FDG uptake in primary gastric malignant lymphoma correlates with glucose transporter 1 expression and histologic malignant potential.

Watanabe Y, Suefuji H, Hirose Y, Kaida H, Suzuki G, Uozumi J, Ogo E, Miura M, Takasu K, Miyazaki K, Nakahara K, Ishibashi M, Okamura T, Ohshima K, Hayabuchi N.

Int J Hematol. 2013 Jan;97(1):43-9. doi: 10.1007/s12185-012-1225-4. Epub 2012 Dec 2.

PMID:
23212465
19.

18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression.

Yen TC, See LC, Lai CH, Yah-Huei CW, Ng KK, Ma SY, Lin WJ, Chen JT, Chen WJ, Lai CR, Hsueh S.

J Nucl Med. 2004 Jan;45(1):22-9.

20.

Clinical implication of glucose transport and metabolism evaluated by 18F-FDG PET in hepatocellular carcinoma.

Paudyal B, Paudyal P, Oriuchi N, Tsushima Y, Nakajima T, Endo K.

Int J Oncol. 2008 Nov;33(5):1047-54.

PMID:
18949368
Items per page

Supplemental Content

Write to the Help Desk